434 related articles for article (PubMed ID: 27777153)
1. Hypofractionated Stereotactic Radiosurgery and Radiotherapy to Large Resection Cavity of Metastatic Brain Tumors.
Lima LC; Sharim J; Levin-Epstein R; Tenn S; Teles AR; Kaprealian T; Pouratian N
World Neurosurg; 2017 Jan; 97():571-579. PubMed ID: 27777153
[TBL] [Abstract][Full Text] [Related]
2. HFSRT of the resection cavity in patients with brain metastases.
Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
[TBL] [Abstract][Full Text] [Related]
3. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
4. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
[TBL] [Abstract][Full Text] [Related]
5. Postoperative Stereotactic Radiosurgery Using 5-Gy × 5 Sessions in the Management of Brain Metastases.
Abuodeh Y; Ahmed KA; Naghavi AO; Venkat PS; Sarangkasiri S; Johnstone PAS; Etame AB; Yu HM
World Neurosurg; 2016 Jun; 90():58-65. PubMed ID: 26921701
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy.
Broemme J; Abu-Isa J; Kottke R; Beck J; Wiest R; Malthaner M; Schmidhalter D; Raabe A; Aebersold DM; Pica A
Strahlenther Onkol; 2013 Sep; 189(9):765-70. PubMed ID: 23934329
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases.
Minniti G; Paolini S; D'Andrea G; Lanzetta G; Cicone F; Confaloni V; Bozzao A; Esposito V; Osti M
J Neurooncol; 2017 May; 132(3):455-462. PubMed ID: 28260130
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer : Evaluation of indications and predictors of local control.
Ishihara T; Yamada K; Harada A; Isogai K; Tonosaki Y; Demizu Y; Miyawaki D; Yoshida K; Ejima Y; Sasaki R
Strahlenther Onkol; 2016 Jun; 192(6):386-93. PubMed ID: 27169391
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique.
Kelly PJ; Lin YB; Yu AY; Alexander BM; Hacker F; Marcus KJ; Weiss SE
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):95-101. PubMed ID: 21168282
[TBL] [Abstract][Full Text] [Related]
11. Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.
Garimall S; Shanker M; Johns E; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
J Neurooncol; 2020 Jan; 146(2):357-362. PubMed ID: 31907796
[TBL] [Abstract][Full Text] [Related]
12. Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control.
Prabhu R; Shu HK; Hadjipanayis C; Dhabaan A; Hall W; Raore B; Olson J; Curran W; Oyesiku N; Crocker I
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e61-6. PubMed ID: 22516387
[TBL] [Abstract][Full Text] [Related]
13. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
16. Single-fraction versus hypofractionated stereotactic radiosurgery for medium-sized brain metastases of 2.5 to 3 cm.
Chon H; Yoon K; Lee D; Kwon DH; Cho YH
J Neurooncol; 2019 Oct; 145(1):49-56. PubMed ID: 31420793
[TBL] [Abstract][Full Text] [Related]
17. Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases.
Soliman H; Myrehaug S; Tseng CL; Ruschin M; Hashmi A; Mainprize T; Spears J; Das S; Yang V; da Costa L; Maralani P; Heyn C; Atenafu EG; Sahgal A
Neurosurgery; 2019 Nov; 85(5):E860-E869. PubMed ID: 31173150
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic fractionated radiotherapy of the resection cavity in patients with one to three brain metastases.
Bilger A; Milanovic D; Lorenz H; Oehlke O; Urbach H; Schmucker M; Weyerbrock A; Nieder C; Grosu AL
Clin Neurol Neurosurg; 2016 Mar; 142():81-86. PubMed ID: 26816106
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Radiosurgery for Melanoma Brain Metastases: A Comprehensive Clinical Case Series.
Feng R; Oermann EK; Shrivastava R; Gold A; Collins BT; Kondziolka D; Collins SP
World Neurosurg; 2017 Apr; 100():297-304. PubMed ID: 28093345
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Dose-Staged Gamma Knife Radiosurgical Treatment Method for High-Risk Brain Metastases.
Frischer JM; Fraller A; Mallouhi A; Vogl UM; Baier F; Ertl A; Preusser M; Knosp E; Kitz K; Gatterbauer B
World Neurosurg; 2016 Oct; 94():352-359. PubMed ID: 27443227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
